The Influence of Piriform Recess Instillation with Lidocaine Before Bronchoscopy on Post-General Anesthesia Cough: A Randomized Controlled Trial
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s458058 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Keting Min und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Lidocaine, Cough, Bronchoscopy, Anesthesia, General. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
ORCID-Profile: Xin Lv
Zitieren
APA
Min, K., Wang, Y., Feng, D., Jin, T., Zhu, W., Duan, R., & Lv, X. (2024). The Influence of Piriform Recess Instillation with Lidocaine Before Bronchoscopy on Post-General Anesthesia Cough: A Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s458058
Vancouver
Min K, Wang Y, Feng D, Jin T, Zhu W, Duan R, et al. The Influence of Piriform Recess Instillation with Lidocaine Before Bronchoscopy on Post-General Anesthesia Cough: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s458058
BibTeX
@article{Min2024,
author = {Min, Keting and Wang, Yu and Feng, Di and Jin, Tian and Zhu, Wanli and Duan, Ruowang and Lv, Xin},
title = {The Influence of Piriform Recess Instillation with Lidocaine Before Bronchoscopy on Post-General Anesthesia Cough: A Randomized Controlled Trial},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s458058}
}
EUVIMED